The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease

As non-operative management (NOM) of esophageal and rectal cancer is becoming more prevalent, blood-biomarkers such as circulating tumor DNA (ctDNA) may provide clinical information in addition to endoscopy and imaging to aid in treatment decisions following chemotherapy and radiation therapy. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Boniface, Christopher, Deig, Christopher, Halsey, Carol, Kelley, Taylor, Heskett, Michael B., Thomas, Charles R., Spellman, Paul T., Nabavizadeh, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824834/
https://www.ncbi.nlm.nih.gov/pubmed/33466369
http://dx.doi.org/10.3390/diagnostics11010073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824834/
https://www.ncbi.nlm.nih.gov/pubmed/33466369
http://dx.doi.org/10.3390/diagnostics11010073

Ejemplares similares